- 24/7 Wall St.•9 minutes ago
The October 14 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest was mixed.
- Associated Press•12 hours ago
A former Oppenheimer & Co. Inc. financial adviser pleaded guilty to insider trading charges on Tuesday, admitting that he earned hundreds of thousands dollars illegally over a six-year period by using ...
- Reuters•14 hours ago
A former investment adviser at an Oppenheimer Holdings Inc unit pleaded guilty on Tuesday to charges that he engaged in an insider trading scheme based on information supplied by a childhood friend working at Pfizer Inc. David Hobson, 48, entered his plea in Manhattan federal court to conspiracy and securities fraud charges over conduct that began while he was at Royal Bank of Canada unit RBC Capital Markets and then continued at Oppenheimer & Co Inc. Hobson, a Providence, Rhode Island, resident, admitted that he executed trades based on inside information supplied by Michael Maciocio, a friend at Pfizer who pleaded guilty in May as part of a deal to cooperate with prosecutors.
Pfizer Inc. (PFE)
NYSE - NYSE Real Time Price. Currency in USD
|Bid||32.16 x 500|
|Ask||32.30 x 100|
|Day's Range||31.99 - 32.37|
|52wk Range||28.25 - 37.39|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||28.62|
|Avg Vol (3m)||19,076,441|
|Dividend & Yield||1.20 (3.73%)|